Aehr Test Systems (AEHR) Stock Price & How to Invest
Last updated November 2026
Short answer
You can invest in Aehr Test Systems (AEHR) by buying shares or fractional shares at any major broker, through an ETF that holds it, or as one holding in a thematic basket. Aehr makes semiconductor test and burn-in systems, a specialized niche in the chip supply chain: its FOX wafer-level and Sonoma package-level systems screen chips for reliability before they ship. The thesis is that Aehr is diversifying from electric-vehicle silicon carbide, where demand has softened, toward AI processor, data center, and silicon photonics burn-in, a market it believes is several times larger. As of October 16, 2026 the stock closed near $64.93, up about 193% for the year but down about 34% over three months. The biggest risks are heavy customer concentration, new competition worries, the EV/SiC slowdown, and the lumpy, cyclical nature of a small-cap equipment supplier.
AEHR stock price
As of 2026-11-16, Aehr Test Systems (AEHR) last closed at $50.98, up 154.0% over the past year. Over the past 52 weeks it has traded between $19.40 and $145.61.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Aehr Test Systems's investor relations page. Walnut is informational, not investment advice.
AEHR key stats
At $50.98 on November 16, 2026, Aehr Test Systems (AEHR) has a market cap of $1.7B.
- Market cap
- $1.7B
- P/E (forward)
- 30.3
- Price to book
- 7.5
- Beta
- 3.33
Market cap, P/E and yield are measured at the $50.98 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.
What's new with Aehr Test Systems (AEHR)?
The last two weeks for Aehr Test Systems, as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.
- AEHR closed at $50.98 on November 16, 2026, down 14.8% over the past five trading days (from $59.81).
- On November 6, 2026, Aehr Test Systems filed its quarterly report (10-Q) with the SEC. Read the 10-Q on sec.gov
- On November 3, 2026, Lake Street lowered its target to $90.00 from $110.00 (Buy).
- On November 3, 2026, Jefferies lowered its target to $140.00 from $175.00 (Buy).
Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.
What does Aehr Test Systems (AEHR) do?
Aehr Test Systems, headquartered in Fremont, California, designs and sells semiconductor test and burn-in equipment. Its FOX-P platform (FOX-XP and FOX-NP systems, plus WaferPak full-wafer contactors and DiePak carriers) performs wafer-level and singulated-die test, burn-in, and stabilization, processes that stress chips at elevated voltage and temperature to weed out early-life failures before the parts reach customers. Aehr also added ultra-high-power Sonoma systems for package-level burn-in of high-wattage devices. The company is one of the few suppliers offering both wafer-level and package-level burn-in across silicon carbide, gallium nitride, AI processors, silicon photonics, and flash memory.
The numbers have started to turn. In the fiscal fourth quarter ended May 2026, revenue rose to about $18.8 million from about $10.3 million the quarter before, and Aehr earned about $1.4 million, or $0.11 per share against a consensus estimate of roughly a $0.01 loss. Full fiscal 2026 revenue was still only about $50 million with a net loss of about $7.1 million, so the market cap of about $2.1 billion rests on what comes next: analysts expect fiscal 2027 revenue of about $136 million. In October 2026 Aehr announced about $6 million of follow-on Sonoma orders for its lead hyperscale customer's second AI processor, while the stock sold off after Teradyne introduced its Titan HP test platform. Fiscal first-quarter 2027 results are scheduled for November 2, 2026.
What's driving Aehr Test Systems (AEHR)?
1. AI and data center diversification.
Aehr has pivoted its growth story from electric-vehicle silicon carbide toward burn-in of AI processors, custom ASICs, and data center chips. Its lead hyperscale customer's first AI processor is already in high-volume production on Sonoma systems, and on October 7, 2026 Aehr announced about $6 million in follow-on Sonoma orders for that customer's second AI processor, with deliveries over six months and a production ramp expected in calendar 2027. The customer expects the second processor to eventually exceed the first in volume. Management estimates that only roughly 5% of ASICs and about 50% of AI accelerators currently undergo production burn-in, framing the AI processor opportunity as several times larger than its historical silicon carbide market.
2. Silicon photonics and optical interconnect.
As AI clusters scale, optical interconnects and co-packaged optics need reliability screening. Aehr has won and received follow-on orders from silicon photonics customers for fully automated wafer-level burn-in systems serving hyperscale data center optical interconnect, a newer end market that broadens its demand base beyond power devices.
3. New device markets: GaN.
Aehr secured its first gallium nitride (GaN) production order from a leading automotive semiconductor supplier, extending its addressable market beyond silicon carbide into another fast-growing power-device material. GaN and silicon photonics together give Aehr multiple wafer-level burn-in markets rather than a single concentrated one.
4. Installed base and consumables.
Each FOX system uses WaferPak full-wafer contactors and DiePak carriers specific to a customer's device, which can drive repeat consumable and follow-on orders as a customer ramps volume. A growing installed base of systems across SiC, AI, GaN, and photonics customers is the mechanism Aehr is counting on to make revenue less lumpy over time.
What are the risks to Aehr Test Systems (AEHR)?
Customer concentration is heavy: a small number of large semiconductor manufacturers drive most revenue, and the AI story leans on one lead hyperscale customer, so the loss or delay of a single program can swing results materially. Competition concerns flared in October 2026 when Teradyne introduced its Titan HP platform and Aehr shares fell; Oppenheimer argued the two address different test stages (system-level test versus wafer-level burn-in), but the episode shows how sensitive the valuation is. The electric-vehicle and silicon carbide demand that powered prior years has softened, and management has stayed conservative about a SiC recovery. As a small-cap capital-equipment supplier, Aehr's orders are lumpy and tied to customers' capex cycles, which produced a fiscal 2026 net loss of about $7 million. The valuation is demanding: around 42 times trailing sales and about 47 times forward earnings, priced for the AI ramp to arrive roughly on schedule. The stock's 52-week range of about $18.70 to $147.40 shows how violently it can move in both directions.
What is the Aehr Test Systems (AEHR) forecast?
4 analysts publish price targets on AEHR, averaging $123.75 as of November 2026, or +142.7% against the $50.98 share price on November 16, 2026. The published targets run from $110.00 to $140.00, a narrow spread, and the ratings split 5 buy, 0 hold, 0 sell. Over the last six months there have been 0 raises and 2 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.
Read the full AEHR forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.
Is AEHR a buy or a sell?
We give no verdict on Aehr Test Systems. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.
The case for buying. AI and data center diversification. Aehr has pivoted its growth story from electric-vehicle silicon carbide toward burn-in of AI processors, custom ASICs, and data center chips. The most optimistic published target, $140.00, assumes this works close to its best case.
The case against. Customer concentration is heavy: a small number of large semiconductor manufacturers drive most revenue, and the AI story leans on one lead hyperscale customer, so the loss or delay of a single program can swing results materially. The most pessimistic target, $110.00, is roughly what AEHR is worth if this bites instead.
Read the full bull and bear case on AEHR, including what would have to change to break either one. Walnut is not an investment adviser.
Has Aehr Test Systems (AEHR) split its stock?
No. Aehr Test Systems (AEHR) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.
How is Aehr Test Systems (AEHR) valued?
Market cap, P/E and dividend yield at today's price are in the AEHR key stats above. The business figures below come from Aehr Test Systems's reported results as of October 2026 and change when it next reports.
- Revenue (FY2026, ended May 2026): ~$50 million; fiscal Q4 ~$18.8 million, up ~34% year over year
- Net income: FY2026 net loss ~$7.1 million (EPS ~-$0.23); fiscal Q4 profit ~$1.4 million, EPS $0.11 vs ~-$0.01 expected
- Margins (TTM): ~35% gross, ~-6% operating
- Balance sheet: ~$116 million cash, ~$10 million debt
As of October 2026: Aehr swung back to a quarterly profit in fiscal Q4 2026, beating the consensus estimate, but the full fiscal year was still a loss on about $50 million of revenue. The roughly $2.1 billion market value prices in analyst expectations of about $136 million of revenue in fiscal 2027, and the stock has fallen about 34% over three months even after a 193% gain year to date. The next check is fiscal Q1 2027 results on November 2, 2026, where consensus sits near $26.6 million of revenue and $0.09 per share. All figures are approximate as of October 16, 2026.
Who competes with Aehr Test Systems (AEHR)?
Semiconductor test and burn-in specialists
Aehr competes in the niche of reliability test and burn-in. Peers and adjacent suppliers include Cohu, which provides test handlers, contactors, and burn-in solutions, along with various specialized burn-in board and system vendors. Aehr's differentiation is offering both wafer-level and package-level burn-in across SiC, GaN, AI processors, silicon photonics, and flash memory.
Larger automated test equipment (ATE) makers
The broader chip-test market is dominated by far larger automated test equipment companies such as Teradyne and Advantest, which sell system-level testers for logic and memory. These firms operate at much greater scale than Aehr and address different points in the test flow, though they shape the competitive and pricing environment for chip test overall.
In-house and alternative screening
A structural competitor is the option for chipmakers to screen reliability with their own internal methods or to skip production burn-in entirely. Aehr's growth case depends partly on burn-in becoming more standard for AI accelerators and ASICs, where management estimates only a minority of parts are burned in today.
What stocks are similar to Aehr Test Systems (AEHR)?
Other names that sit close to AEHR: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.
How to invest in Aehr Test Systems (AEHR)
There are three common ways to get AEHR exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so AEHR sits alongside other stocks that express the same thesis.
Walnut takes the portfolio route. Describe a thesis where AEHR fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.
The bottom line on Aehr Test Systems (AEHR)
If you believe production burn-in becomes a standard, growing requirement for AI accelerators, custom ASICs, and silicon photonics, and that Aehr can convert its hyperscale AI orders into recurring revenue the way it once did with silicon carbide, then Aehr Test Systems (AEHR) is a focused way to express that view. It is a small-cap, project-driven equipment supplier whose revenue swings with a handful of large customers' capital cycles, and whose share price has nearly tripled in 2026 and then fallen by a third in three months, so most holders treat it as a high-volatility, single-theme position sized inside a broader basket rather than a core holding.
More on Aehr Test Systems (AEHR)
Whether AEHR is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is AEHR a buy or a sell?, and where the stock could go from here in the AEHR stock forecast.
For income investors, whether AEHR pays a dividend and how the payout looks is covered in does AEHR pay a dividend? And to weigh AEHR against a peer, read the full side-by-side comparisons: AEHR vs COHU and AEHR vs TER.
Wondering how AEHR fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Aehr Test Systems
Ask Walnut's AI anything about AEHR and see how it fits what you own.
FAQ
What does Aehr Test Systems do?
+
Aehr Test Systems makes semiconductor test and burn-in equipment. Its FOX-P platform performs wafer-level and singulated-die test, burn-in, and stabilization, stressing chips at elevated voltage and temperature to catch early-life failures before parts ship. It serves silicon carbide, gallium nitride, AI processors, silicon photonics, and flash memory customers, and added Sonoma systems for high-power package-level burn-in.
What is AEHR's ticker symbol and where is it listed?
+
The company trades as AEHR on the Nasdaq, officially Aehr Test Systems, headquartered in Fremont, California. It is a small-cap stock available at every major US brokerage with commission-free trading, and many brokers also offer fractional shares so you can invest a fixed dollar amount.
Is AEHR a good stock to buy right now?
+
Descriptive, not a recommendation. The bull case is Aehr's diversification from softening EV silicon carbide into AI processor, data center, GaN, and silicon photonics burn-in, with follow-on hyperscale AI orders, a return to quarterly profit in fiscal Q4 2026, and analyst forecasts of sharply higher fiscal 2027 revenue. The bear case is heavy customer concentration, a fiscal 2026 net loss, a rich valuation near 42 times sales, new competition worries, and the lumpy, cyclical nature of a small-cap equipment supplier. Whether it fits depends on your goals and risk tolerance. Walnut is informational, not investment advice.
Does AEHR pay a dividend?
+
No. Aehr Test Systems does not pay a dividend, so its yield is 0%. As a small-cap company reinvesting in its business, with about $116 million of cash and roughly $10 million of debt, it is not an income stock; any return would come from share-price changes rather than dividends. The figure is current as of October 2026; verify against Aehr's investor relations page.
How does Aehr benefit from AI?
+
As AI processors, custom ASICs, and optical interconnects scale, more of them may need production burn-in to ensure reliability. Aehr supplies the wafer-level and package-level systems that do this. Its lead hyperscale customer's first AI processor is in high-volume production on Sonoma, and in October 2026 that customer placed about $6 million of follow-on orders for a second AI processor expected to ramp in 2027. Management estimates only a minority of AI accelerators and ASICs are burned in today, which it frames as the growth opportunity.
Why did Aehr's revenue and silicon carbide business decline?
+
Aehr's revenue had been concentrated in silicon carbide power devices used in electric vehicles. As EV demand softened, silicon carbide orders slowed, and fiscal 2026 revenue fell to about $50 million from about $59 million the year before, with a net loss of about $7.1 million. The trough appears to have been mid-year: fiscal Q4 revenue recovered to about $18.8 million and turned a small profit as AI and data center shipments picked up, while management has stayed conservative on a SiC recovery.
What is wafer-level burn-in and why does it matter?
+
Burn-in stresses chips at high voltage and temperature to force early-life defects to fail before the parts reach customers. Wafer-level burn-in does this across an entire wafer at once using full-wafer contactors, which can be more efficient than testing packaged parts. It matters most for devices where reliability is critical, such as power semiconductors and AI processors used in long-running data center workloads.
Which ETFs or funds hold AEHR?
+
As a small-cap semiconductor stock, AEHR appears in small-cap and semiconductor-focused index funds and ETFs rather than large-cap megacap funds, typically at small weights. Holdings shift as funds rebalance, so check a specific ETF's current holdings list with its provider before assuming exposure. Buying the stock directly gives the most concentrated exposure to Aehr's specific test and burn-in thesis.
How did Aehr do in its latest quarter?
+
In fiscal Q4 2026, the quarter ended May 2026, Aehr reported revenue of about $18.8 million, up roughly 34% year over year and up from about $10.3 million the quarter before. It earned about $1.4 million, or $0.11 per share, against a consensus estimate of roughly a $0.01 loss. Fiscal Q1 2027 results are due November 2, 2026, with consensus near $26.6 million of revenue and $0.09 per share.
How has AEHR stock performed in 2026?
+
As of October 16, 2026, AEHR closed near $64.93, up about 193% year to date and about 143% over one year. The ride has been rough: the 52-week range runs from about $18.70 to $147.40, and the shares are down about 30% over the past month and 34% over three months, partly after Teradyne's Titan HP launch raised competition concerns. Walnut is not an investment adviser, and past moves say nothing certain about the future.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Aehr Test Systems's investor relations page or your broker before making investment decisions.